featured
Oral Phosphodiesterase Inhibitor Apremilast for Inflammatory Rosacea
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An Oral Phosphodiesterase Inhibitor (Apremilast) for Inflammatory Rosacea in Adults: A Pilot Study
JAMA Dermatol 2014 Jul 23;[EPub Ahead of Print], BJ Thompson, M Furniss, W Zhao, B Chakraborty, J Mackay-WigganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.